EXAGEN INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Exagen Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Exagen Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$100K, a 61.3% decline year-over-year.
  • Exagen Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$10.6M, a 2074% decline from 2022.
  • Exagen Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$489K, a 101% decline from 2021.
  • Exagen Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $64.7M.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$10.6M -$10.1M -2074% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$489K -$65.2M -101% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $64.7M +$64.8M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$97K -$68.8M -100% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $68.7M +$57.3M +502% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $11.4M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.